Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Carolyn Mulroney

Photo of Carolyn Mulroney
Title(s)Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0003-0441-6137 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE , BALTIMORE, MARYLANDMDMEDICAL SCHOOL
    DUKE UNIVERSITY, DURHAM, NORTH CAROLINAINTERNSHIP AND RESIDENCY INTERNAL MEDICINE
    UNIVERSITY OF WASHINGTON , SEATTLE, WA HEMATOLOGY, BMT
    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO , SAN FRANCISCO,CAHEMATOLOGY AND MEDICAL ONCOLOGY

    Collapse Overview 
    Collapse overview
    Clinical Trials
    Co-Investigator on several clinical trials in the Blood and Marrow Transplantation Division: BMTCTN 0402, IRB # 101006, A Phase III Randomized, Multicenter Trial comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as a Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA- Matched, Related Peripheral Blood Stem Cell transplantation.

    Education and Training
    B.A. - University of Pennsylvania, Philadelphia, PA - 1978-1982
    M.D. - Johns Hopkins University School of Medicine - 1982-1986
    Research Fellowship - American Academy of Allergy and Immunology, John Hopkins University School of Medicine Division of Immunology, Durham, Baltimore, Maryland - 1986
    Intern in Internal Medicine - Duke University School of Medicine, Durham, North Carolina - 1986-1987
    Hematology Fellowship - University of Washington, Seattle, Washington - 1990-1992
    Hematology Oncology Fellow - University of California, San Francisco, CA - 1992

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept. Blood Adv. 2025 Aug 26; 9(16):4336-4344. Koura D, Dykes K, Goodman A, Costello C, Mulroney C, Mangan JK, Tanaka TN, Ball ED, Hamdan A, Jeong AR, Mirocha J, Zhang Q, Ogrodnik P, McConnell K, Maroge JJ, Padilla M, Morris GP, Tzachanis D. PMID: 40554429; PMCID: PMC12402362.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Treatment of an Indolent T-Cell Lymphoma of the Gastrointestinal Tract Harboring STAT3::JAK2 With Jakafi (Ruxolitinib) With Significant Clinical Improvements. EJHaem. 2025 Jun; 6(3):e70047. Cao X, Mulroney C, Wang HY. PMID: 40342616; PMCID: PMC12061073.
      View in: PubMed   Mentions:
    3. Extracorporeal photopheresis for the treatment of chronic graft versus host disease. Hematology. 2022 Dec; 27(1):785-794. Kansu E, Ward D, Sanchez AP, Cunard R, Hayran M, Huseyin B, Vaughan M, Ku G, Curtin P, Mulroney C, Costello C, Castro JE, Wieduwilt M, Corringham S, Ihasz-Davis A, Nelson C, Ball ED. PMID: 35802815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplant Cell Ther. 2022 01; 28(1):30.e1-30.e7. Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R. PMID: 34655803.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    5. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. Transplant Cell Ther. 2022 01; 28(1):48.e1-48.e10. Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveir S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales MA, Riches M. PMID: 34587551; PMCID: PMC9717499.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    6. Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation. Br J Haematol. 2021 07; 194(1):145-157. Mulroney CM, Abid MB, Bashey A, Chemaly RF, Ciurea SO, Chen M, Dandoy CE, Diaz Perez MA, Friend BD, Fuchs E, Ganguly S, Goldsmith SR, Kanakry CG, Kim S, Komanduri KV, Krem MM, Lazarus HM, Ljungman P, Maziarz R, Nishihori T, Patel SS, Perales MA, Romee R, Singh AK, Reid Wingard J, Yared J, Riches M, Taplitz R. PMID: 34124796; PMCID: PMC8853845.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    7. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021 06 10; 137(23):3291-3305. Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Masiarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz R, Romee R, Riches M. PMID: 33657221; PMCID: PMC8351903.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCellsCTClinical Trials
    8. Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. Front Oncol. 2021; 11:620435. Wang HY, Sokol ES, Goodman AM, Feldman AL, Mulroney CM. PMID: 33777766; PMCID: PMC7988195.
      View in: PubMed   Mentions: 1  
    9. Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers (Basel). 2018 Dec 21; 11(1). Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R. PMID: 30583461; PMCID: PMC6356731.
      View in: PubMed   Mentions: 18  
    10. Transfusion practices at end of life for hematopoietic stem cell transplant patients. Support Care Cancer. 2018 Jun; 26(6):1927-1931. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney C, Roeland EJ. PMID: 29285557; PMCID: PMC5924436.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation. J Oncol Pract. 2017 09; 13(9):e721-e728. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney CM, Roeland EJ. PMID: 28644706; PMCID: PMC6366810.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    12. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017 06; 1. Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. PMID: 28681041; PMCID: PMC5495179.
      View in: PubMed   Mentions: 15     Fields:    
    13. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. Int J Clin Exp Pathol. 2014; 7(8):5221-31. Li K, Johnson RL, Li S, Thorson JA, Mulroney CM, Dell'Aquila ML, Wang HY. PMID: 25197401; PMCID: PMC4152091.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support Care Cancer. 2011 Dec; 19(12):2015-20. Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, Shaikh F, Natarajan L. PMID: 21116652; PMCID: PMC3204044.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. The use of photodynamic therapy in bone marrow purging. Semin Oncol. 1994 Dec; 21(6 Suppl 15):24-7. Mulroney CM, Glück S, Ho AD. PMID: 7992104.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    16. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol. 1988 Mar 01; 140(5):1500-5. Lamas AM, Mulroney CM, Schleimer RP. PMID: 3279115.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    17. Epidemiology of pre-invasive and invasive malignant melanoma in Western Australia. Int J Cancer. 1980 Mar 15; 25(3):317-23. Holman CD, Mulroney CD, Armstrong BK. PMID: 7390655.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans